Orvosi Hetilap | 2019
Az egészségbiztosítási gyógyszerkiadások alakulása Magyarországon
Abstract
INTRODUCTION In Hungary, health expenditures - especially the question of health insurance subsidies for medicinal products - are becoming increasingly important. AIM The aim of our analysis is to reveal the state s health insurance expenditure between 2010 and 2016 as well as the amount of health insurance subsidies for medicinal products. DATA AND METHODS Data were derived from the database of the National Health Insurance Fund of Hungary and of the Hungarian Central Statistical Office. During the analysis we examined the period between 2010 and 2016. We analysed the health expenditures in proportion to the gross domestic product (GDP) as well as the changes of drug traffic based on gross consumer prices and those of health insurance subsidies, and also our regional inequalities. When writing the present study, we used descriptive statistical methods. RESULTS The expenditures of the National Health Insurance Fund of Hungary significantly increased as proportions of the GDP from 5.5% in 2010 to 6.1% in 2016. The health insurance subsidies for medicinal products increased since 2013. The highest health insurance subsidies per 10\xa0000 inhabitants could be seen in Baranya (405\xa0788 HUF/inhabitant) and Csongrad (384\xa0724 HUF/inhabitant) counties and in Budapest (377\xa0316 HUF/inhabitant). The lowest health insurance subsidies were found in Nograd (289\xa0168 HUF/inhabitant) and Szabolcs-Szatmar-Bereg (271\xa0104 HUF/inhabitant) counties. CONCLUSION The trends of health and drug expenditure show a growing tendency. We can find significant regional inequalities in case of both the drug traffic based on gross consumer prices and the health insurance subsidies. It would be needed to strengthen the elements of prevention, and to popularize health-conscious lifestyle and doing sports. Orv Hetil. 2019; 160(Suppl 1): 49-54.